MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.omton.2026.201205

Медицинская библиотека · Molecular therapy. Oncology · 2026

NeuroD1 gene therapy inhibits glioma growth and extends life span through in vivo reprogramming approach.

Chen Yuchen, Jiang Zuoyu, Jin Sen, Liu Meng, Chen Ming, Kuo Tsang-Chih, Zhou Kai, Pu Liting, Chen Ming, Chen Shiyuan, Li Xuetao, Chen Adalia S, Xie Jingmu, Zhang Huitao, Wang Qingsong, Xu Jie, Sheng Jian, Huang Yulun, Chen Gong

СтатьяПеревод пока не подготовлен

Аннотация

Glioblastoma(GBM), a highly aggressive primary brain tumor characterized by rapid progression, frequent recurrence, and limited clinical options, remains one of the most lethal central nervous system malignancies. Here, we report a gene therapy strategy to treat glioma utilizing NeuroD1, a neurogenic transcription factor with demonstrated capacity to reprogram both glial cells and GBM cells into neuronal lineages. We developed a self-complementary adeno-associated virus (scAAV) vector, scAAV6-NeuroD1, and evaluated its therapeutic potential across in vitro and in vivo GBM models, including multiple GBM cell lines, patient-derived organoids, and orthotopic models in immunodeficient mice. Our findings reveal that scAAV6-NeuroD1 preferentially infects glioma cells and induces dual therapeutic effects by simultaneously inhibiting glioma cell proliferation and inducing neuronal reprogramming. Importantly, scAAV6-NeuroD1-treated mice with orthotopic GBM transplants exhibited reduced tumor burden, infiltration of T cells into the glioma, attenuated tumor-induced body weight loss, and dose-dependent survival extension. Analysis of published patient datasets further revealed that high NeuroD1 expression level correlates with improved overall survival and lower tumor malignancy grade. Together, these findings position scAAV6-NeuroD1 as a promising therapeutic candidate, potentially redefining the therapeutic landscape for GBM.

Для цитирования: Chen Yuchen, Jiang Zuoyu, Jin Sen, Liu Meng, Chen Ming, Kuo Tsang-Chih, Zhou Kai, Pu Liting, Chen Ming, Chen Shiyuan, Li Xuetao, Chen Adalia S, Xie Jingmu, Zhang Huitao, Wang Qingsong, Xu Jie, Sheng Jian, Huang Yulun, Chen Gong. NeuroD1 gene therapy inhibits glioma growth and extends life span through in vivo reprogramming approach.. Molecular therapy. Oncology. 2026. DOI: 10.1016/j.omton.2026.201205.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.